AveXis Inc buy melinda
Start price
07.10.17
/
50%
€93.54
Target price
26.12.17
€99.22
Performance (%)
6.50%
End price
26.12.17
€99.62
Summary
This prediction ended on 26.12.17 with a price of €99.62. The BUY prediction by melinda finished with a performance of 6.50%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| AveXis Inc | - | - | - | - |
| iShares Core DAX® | -3.033% | 0.651% | 12.268% | 18.187% |
| iShares Nasdaq 100 | -3.554% | -3.007% | 27.682% | 47.279% |
| iShares Nikkei 225® | -3.938% | 1.935% | 10.515% | 10.489% |
| iShares S&P 500 | -1.517% | -0.602% | 25.859% | 45.572% |
Comments by melinda for this prediction
In the thread AveXis Inc diskutieren
Geschäft mit Therapien auf Basis von Nukleinsäure-Targeting monogenen Erkrankungen des ZNS
Sektor
Biotechnologie und medizinische Forschung